Innoviva Inc - Company Profile
Powered by
All the data and insights you need on Innoviva Inc in one report.
- Save hours of research time and resources with
our up-to-date Innoviva Inc Strategy Report
- Understand Innoviva Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Innoviva Inc (Innoviva) develops, commercializes, and enables financial management of bio-pharmaceuticals in areas of unmet medical needs. It partners with life sciences companies to advance innovative pharmaceutical therapies. Increase in working capital, core product of Relvar/Breo and collaboration with Glaxo Group Ltd (GSK) are its major strengths, even as substantial debt is a cause for concern to the company. Innoviva could benefit from the growing market potential of global anesthesia and respiratory devices market; strategic agreements, and increasing healthcare expenditure in the US. Dependence on third parties, requirements of payors and industry consolidation, and stringent regulations could affect the company's growth.
Strengths
Weaknesses
Opportunities
- Market Potential: Global Anesthesia and Respiratory Devices Market
- Lorem ipsum
- Lorem ipsum
- Lorem ipsum
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer